Furthermore, MELK has previously been shown to be positively regulated by Hes6 (Fig EV4D) and is part of a HES6‐associated signature that predicts poor outcome in prostate cancer (Ramos‐Montoya et al, 2014). The gene discussed is HES6; the disease is prostate cancer.